Press Releases

Gene Delivery System Market at a CAGR of over 7.8% from 2017 to 2030

Gene Delivery System Market: Snapshot

Gene delivery systems are used to deliver therapeutic drugs targeting a specific area. Gene delivery is a procedure that introduces foreign DNA into host cells. The global gene delivery system market was valued approximately US$ 2,227.8 Mn in 2016 and is anticipated to expand at a CAGR of over 7.8% from 2017 to 2025 to reach value of nearly US$ 4,281.0 Mn by 2025. Increase in demand for targeted therapies and rise in technological advancements are likely to fuel the global gene delivery system market from 2017 to 2025.

Get the sample copy of report@ https://qyresearchmedical.com/sample/112012

The global gene delivery system market is driven by increase in need for advanced technologies for targeted systems. Launch of new and advanced technologies, rise in demand for targeted and low dose frequency drug delivery, increase in investment in research & development, surge in demand for self-administration devices for home health care, and increase in prevalence of chronic life-threatening diseases are driving the global gene delivery system market. However, high cost of the treatment and increase in drug recalls due to stringent regulations in developed countries are likely to restrain the market. The global gene delivery system market is segmented according to delivery system, application, route of administration, and geography.

According to delivery system, the global gene delivery system market is divided into viral gene delivery system, non-viral gene delivery system, and combined hybrid system. The viral gene delivery system is further classified into adenovirus system, lentivirus vector, retrovirus vector, adeno-associated virus vector, sendai virus vector, herpes simplex virus vector, and others. The non-viral gene delivery system is further segmented into natural organic compounds, physical methods, and chemical methods. In terms of revenue, the viral gene delivery system segment dominates the global gene delivery system market. Increase in demand for viral gene delivery systems for the treatment of genetic and acquired diseases caused by insertion or deletion of a gene drives the segment. The combined hybrid delivery system segment account for a small share of the market.

Based on application, the global gene delivery system market is segregated into infectious diseases, oncology, ophthalmology, urology, diabetes, CNS, and others. In terms of revenue, the oncology segment dominates the global gene delivery system market. Rise in incidence of cancer across all regions drives the global gene delivery systems market. According to WHO report (2017), around 1 in 6 deaths occurs due to cancer globally. CNS is the second largest segment boosting the market. Increase in incidence of neurological diseases is likely to drive the segment by 2025. According to EurekAlert, neurological disorders is a leading cause of death globally. Diabetes is also a chronic disease which affects majority of population across the globe. According to WHO report, in 2016, around 1% of total deaths occurred only due to diabetes in Japan.

View full report@ https://qyresearchmedical.com/report/gene-delivery-system-market-delivery-system-viral-gene-delivery-system-adenovirus-system-lentivirus-vector-retrovirus-vector-adeno-associated-virus-vector-sendai-virus-vector-herpes-simplex-virus-vector-an-017-2030/112012

In terms of route of administration, the global gene delivery system market is segmented into oral, injectable, inhalation, transdermal, ocular, nasal, topical, and others. The injectable segment dominates the global gene delivery system market. The oral and injectable segments together accounted for 62.4% share of the market in 2016. The injectable route of administration is used for rapid drug absorption. Especially, drugs with low oral bioavailability are administered through the intramuscular or subcutaneous route. Oral formulations are inexpensive as compared to other dosage forms. This route of drug administration allows sustained release of formulation to reduce the frequency of the medication. These are some of the factors driving the segment. The inhalation segment accounts for less share of the global gene delivery system market. Drugs targeted for the treatment of lung diseases such as bronchodilators and steroids can be inhaled to achieve rapid action. This is likely to boost the segment.

Based on geography, the global gene delivery system market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global gene delivery system market. North America and Europe together accounted for 72.4% share of the market in 2016. Rise in prevalence of chronic diseases in the U.S. and Europe and technological advancement in drug delivery systems are driving the global gene delivery market. Rise in prevalence of acute and chronic diseases in the U.S. drives demand for drug delivery systems in the country. According to WHO report (2016), cancer accounts for around 23% of total deaths in the U.S. Demand for drug and gene delivery system is increasing in the region due to increase in prevalence of several chronic diseases. According to WHO report 2016, around 40% of total death in Germany were caused by cardiovascular diseases. The global gene delivery system market in Asia Pacific is projected to expand at a rapid pace due to increase in prevalence of diseases and rise in investment of key players in this region. The market in Middle East & Africa is likely to expand at a sluggish pace.

Major players operating in the global gene delivery system market include Novartis AG, Amgen Inc., Oxford BioMedia plc, SIBIONO, Shanghai Sunway Biotech Co. Ltd., Pfizer Inc., Bayer AG, Johnson & Johnson Services Inc., Human Stem Cells Institue, and Epeius Biotechnologies Corporation. These players adopt organic and in-organic growth strategies to expand their product offerings, expand geographically, increase customer base, and garner market share.

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/112012/2900

The global gene delivery system market has been segmented as follows:

by Delivery System

  • Viral Gene Delivery
  • Adenovirus Vector
  • Lentivirus Vector
  • Retrovirus Vector
  • Adeno-associated Virus Vector
  • Sendai Virus Vector
  • Herpes Simplex Virus Vector
  • Others
  • Non-viral Gene Delivery
  • Natural Organic Compounds
  • Physical Methods
  • Chemical Methods
  • Combined Hybrid Delivery System

by Application

  • Infectious Diseasess
  • Oncology
  • Ophthalmology
  • Urology
  • Diabetes
  • CNS
  • Others

by Route of Administration

  • Oral
  • Injectable
  • Inhalation
  • Transdermal
  • Ocular
  • Nasal
  • Topical

by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • India
  • Japan
  • China
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC Countries
  • Israel
  • South Africa
  • Rest of MEA

TABLE OF CONTENT

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Gene Delivery System Market

4. Market Overview
4.1. Introduction
4.1.1. Delivery System Definition
4.2. Overview
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunities
4.5. Global Gene Delivery System Market Analysis and Forecasts, 2015–2025
4.5.1. Market Revenue Projections (US$ Mn)
4.6. Porter’s Five Force Analysis
4.7. Market Outlook
4.8. Technological Advancements in Gene Delivery Products
4.9. Regulatory Scenario
4.10. Gene Therapy Pipeline Molecules

5. Global Gene Delivery System Market Analysis and Forecasts, by Delivery System
5.1. Introduction & Definition
5.2. Key Findings
5.4. Market Value Forecast by Delivery System, 2015–2025
5.4.1. Viral Gene Delivery
5.4.1.1. Adenovirus Vector
5.4.1.2. Lentivirus Vector
5.4.1.3. Retrovirus Vector
5.4.1.4. Adeno-associated Virus Vector
5.4.1.5. Sendai Virus Vector
5.4.1.6. Herpes Simplex Virus Vector
5.4.1.7. Others
5.4.2. Non-viral Gene Delivery
5.4.2.1. Natural Organic Compounds
5.4.2.2. Physical Methods
5.4.2.3. Chemical Methods
5.4.3. Combined Hybrid Delivery System
5.5. Market Attractiveness by Delivery System

6. Global Gene Delivery System Market Analysis and Forecasts, by Application
6.1. Introduction & Definition
6.2. Key Findings
6.4. Market Value Forecast by Application, 2015–2025
6.4.1. Infectious Diseases
6.4.2. Oncology
6.4.3. Ophthalmology
6.4.4. Urology
6.4.5. Diabetes
6.4.6. CNS
6.4.7. Others
6.5. Market Attractiveness by Application

7. Global Gene Delivery System Market Analysis and Forecasts, by Route of Administration
7.1. Introduction & Definition
7.2. Key Findings
7.4. Market Value Forecast by Route of Administration, 2015–2025
7.4.1. Oral
7.4.2. Injectable
7.4.3. Inhalation
7.4.4. Transdermal
7.4.5. Ocular
7.4.6. Nasal
7.4.7. Topical
7.5. Market Attractiveness by Route of Administration

8. Global Gene Delivery System Market Analysis and Forecasts, by Region
8.1. Key Findings
8.2. Market Value Forecast by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness by Region

9. North America Gene Delivery System Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast by Delivery System, 2015–2025
9.2.1. Viral Gene Delivery
9.2.1.1. Adenovirus Vector
9.2.1.2. Lentivirus Vector
9.2.1.3. Retrovirus Vector
9.2.1.4. Adeno-associated Virus Vector
9.2.1.5. Sendai Virus Vector
9.2.1.6. Herpes Simplex Virus Vector
9.2.1.7. Others
9.2.2. Non-viral Gene Delivery
9.2.2.1. Natural Organic Compounds
9.2.2.2. Physical Methods
9.2.2.3. Chemical Methods
9.2.3. Combined Hybrid Delivery System
9.3. Market Value Forecast by Application, 2015–2025
9.3.1. Infectious Diseases
9.3.2. Oncology
9.3.3. Ophthalmology
9.3.4. Urology
9.3.5. Diabetes
9.3.6. CNS
9.3.7. Others
9.4. Market Value Forecast by Route of Administration, 2015–2025
9.4.1. Oral
9.4.2. Injectable
9.4.3. Inhalation
9.4.4. Transdermal
9.4.5. Ocular
9.4.6. Nasal
9.4.7. Topical
9.5. Market Value Forecast by Country, 2015–2025
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. by Delivery System
9.6.2. by Application
9.6.3. by Route of Administration
9.6.4. by Country

10. Europe Gene Delivery System Market Analysis and Forecast

……

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/112012/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi

Show More

Related Articles

Back to top button